Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From target discovery to clinical drug development with human genetics
Katerina Trajanoska, Claude Bhérer, Daniel Taliun, et al.
Nature (2023) Vol. 620, Iss. 7975, pp. 737-745
Closed Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Refining the impact of genetic evidence on clinical success
Eric Vallabh Minikel, Jeffery L. Painter, Coco Chengliang Dong, et al.
Nature (2024) Vol. 629, Iss. 8012, pp. 624-629
Open Access | Times Cited: 88
RNAi-based drug design: considerations and future directions
Qi Tang, Anastasia Khvorova
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 5, pp. 341-364
Open Access | Times Cited: 73
Genetic and molecular architecture of complex traits
Tuuli Lappalainen, Yang Li, Sohini Ramachandran, et al.
Cell (2024) Vol. 187, Iss. 5, pp. 1059-1075
Open Access | Times Cited: 21
A DNA language model based on multispecies alignment predicts the effects of genome-wide variants
Gonzalo Benegas, Carlos Albors, Alan J. Aw, et al.
Nature Biotechnology (2025)
Closed Access | Times Cited: 5
Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction
Danielle Rasooly, Claudia Giambartolomei, Gina M. Peloso, et al.
Nature Cardiovascular Research (2025)
Closed Access | Times Cited: 2
Refining the impact of genetic evidence on clinical success
Eric Vallabh Minikel, Jeffery L. Painter, Coco Chengliang Dong, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 23
Genetic factors associated with reasons for clinical trial stoppage
Olesya Razuvayevskaya, Irene Lopez, Ian Dunham, et al.
Nature Genetics (2024) Vol. 56, Iss. 9, pp. 1862-1867
Open Access | Times Cited: 11
Drug-target Mendelian randomization analysis supports lowering plasma ANGPTL3, ANGPTL4, and APOC3 levels as strategies for reducing cardiovascular disease risk
Fredrik Landfors, Peter Henneman, Elin Chorell, et al.
European Heart Journal Open (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 9
Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options
Xiang Zhang, Harry Cheuk-Hay Lau, Jun Yu
Pharmacological Reviews (2025) Vol. 77, Iss. 2, pp. 100018-100018
Open Access | Times Cited: 1
Discovery of drug targets for heart failure with preserved and reduced ejection fraction
Scott C. Ritchie
Nature Cardiovascular Research (2025)
Closed Access | Times Cited: 1
Drug development advances in human genetics‐based targets
X. Zhang, Wenjun Yu, Yan Li, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 7
CAR-T therapy and targeted treatments: Emerging combination strategies in solid tumors
Jiahao Liu, Xiaofei Jiao, Ding Ma, et al.
Med (2024) Vol. 5, Iss. 6, pp. 530-549
Closed Access | Times Cited: 7
Common pitfalls in drug target Mendelian randomization and how to avoid them
Dipender Gill, Marie‐Joe Dib, Héléne T. Cronjé, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy
Bemrew Admassu Mengistu, Tirunesh Tsegaw, Yitayew Demessie, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
GPN-MSA: an alignment-based DNA language model for genome-wide variant effect prediction
Gonzalo Benegas, Carlos Albors, Alan J. Aw, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 13
Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome
Yi Chen, Guiquan Wang, Jingqiao Chen, et al.
Endocrine Reviews (2024) Vol. 45, Iss. 4, pp. 437-459
Open Access | Times Cited: 5
Nominating novel proteins for anxiety via integrating human brain proteomes and genome-wide association study
Xing Jin, Shuangshuang Dong, Yang Yang, et al.
Journal of Affective Disorders (2024) Vol. 358, pp. 129-137
Closed Access | Times Cited: 4
Genetics of rheumatoid arthritis
Seema Sharma, Shek H. Leung, Sébastien Viatte
Best Practice & Research Clinical Rheumatology (2024), pp. 101968-101968
Open Access | Times Cited: 4
Integrating bioinformatics and multiple machine learning to identify mitophagy-related targets for the diagnosis and treatment of diabetic foot ulcers: evidence from transcriptome analysis and drug docking
Hui Guo, Kui Xiao, Yanhua Zheng, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 4
Drug-target Mendelian randomisation applied to metabolic dysfunction-associated steatotic liver disease: opportunities and challenges
Shan Luo, Ming‐Hua Zheng, Vincent Wai‐Sun Wong, et al.
eGastroenterology (2024) Vol. 2, Iss. 4, pp. e100114-e100114
Open Access | Times Cited: 4
Promising But Not Yet the Promised Land
Daphne T. Hsu
JACC Basic to Translational Science (2025) Vol. 10, Iss. 2, pp. 167-169
Open Access
Integrative genetics and multiomics analysis reveal mechanisms and therapeutic targets in vitiligo highlighting JAK STAT pathway regulation of CTSS
Zi-yue Dong, Mingjie He, Yongkai Yu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Unraveling Mechanisms of Genetic Risks in Metabolic Dysfunction–Associated Steatotic Liver Diseases: A Pathway to Precision Medicine
Xiang Zhang, Kyong–Mi Chang, Jun Yu, et al.
Annual Review of Pathology Mechanisms of Disease (2025) Vol. 20, Iss. 1, pp. 375-403
Closed Access
A replication study of novel fetal hemoglobin-associated genetic variants in sickle cell disease-only cohorts
Yann Ilboudo, Nicolas Brosseau, Ken Sin Lo, et al.
Human Molecular Genetics (2025)
Closed Access
Glucokinase Regulatory Protein as a Putative Target for Gestational Diabetes Mellitus and Related Complications: Evidence From the Mendelian Randomization Study
Weian Mao, Guiquan Wang, Xiao Wang, et al.
Journal of Diabetes (2025) Vol. 17, Iss. 2
Open Access
Page 1 - Next Page

Scroll to top